Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers


  Bladder Cancer

  Free Subscription


1 Ann Hum Biol
1 Ann N Y Acad Sci
1 Ann R Coll Surg Engl
1 Bioengineered
1 Biomed Pharmacother
1 BMC Cancer
1 Cancer Lett
1 Cancers (Basel)
1 Cells
1 Cent Eur J Immunol
1 Curr Opin Urol
1 Eur Rev Med Pharmacol Sci
1 Eur Urol Oncol
1 J Biomed Mater Res A
1 Matrix Biol
1 Mol Cancer Ther
1 Nat Rev Urol
1 Nucleic Acids Res
1 Proc Natl Acad Sci U S A
1 Res Rep Urol
1 Sci Rep
4 Transl Androl Urol
3 Urol Oncol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Hum Biol

  1. SORENSEN KK, Jensen BW, Thomas PE, Madsen K, et al
    Early life body size and its associations with adult bladder cancer.
    Ann Hum Biol. 2020;47:166-172.
    PubMed         Abstract available

    Ann N Y Acad Sci

  2. GHASEMI H, Mousavibahar SH, Hashemnia M, Karimi J, et al
    Tissue stiffness contributes to YAP activation in bladder cancer patients undergoing transurethral resection.
    Ann N Y Acad Sci. 2020 May 19. doi: 10.1111/nyas.14358.
    PubMed         Abstract available

    Ann R Coll Surg Engl

  3. JONES P, Eldakhakhny M, Hawary A
    Haematuria caused by bladder cancer in the paediatric setting.
    Ann R Coll Surg Engl. 2020 May 21:e1-e2. doi: 10.1308/rcsann.2020.0108.
    PubMed         Abstract available


  4. HU Y, Zhang Y, Gao J, Lian X, et al
    The clinicopathological and prognostic value of CD44 expression in bladder cancer: a study based on meta-analysis and TCGA data.
    Bioengineered. 2020;11:572-581.
    PubMed         Abstract available

    Biomed Pharmacother

  5. LI Q, Wang S, Wu Z, Liu Y, et al
    DDX11-AS1exacerbates bladder cancer progression by enhancing CDK6 expression via suppressing miR-499b-5p.
    Biomed Pharmacother. 2020;127:110164.
    PubMed         Abstract available

    BMC Cancer

  6. RIPPING TM, Kiemeney LA, van Hoogstraten LMC, Witjes JA, et al
    Insight into bladder cancer care: study protocol of a large nationwide prospective cohort study (BlaZIB).
    BMC Cancer. 2020;20:455.
    PubMed         Abstract available

    Cancer Lett

  7. LI Y, Li G, Guo X, Yao H, et al
    Non-coding RNA in bladder cancer.
    Cancer Lett. 2020 May 10. pii: S0304-3835(20)30225.
    PubMed         Abstract available

    Cancers (Basel)

  8. ECKSTEIN M, Epple E, Jung R, Weigelt K, et al
    CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node Stage.
    Cancers (Basel). 2020;12.
    PubMed         Abstract available


  9. WU Q, Wong JPC, Kwok HF
    Putting the Brakes on Tumorigenesis with Natural Products of Plant Origin: Insights into the Molecular Mechanisms of Actions and Immune Targets for Bladder Cancer Treatment.
    Cells. 2020;9.
    PubMed         Abstract available

    Cent Eur J Immunol

  10. KRAJEWSKI W, Karabon L, Partyka A, Tomkiewicz A, et al
    Polymorphisms of genes encoding cytokines predict the risk of high-grade bladder cancer and outcomes of BCG immunotherapy.
    Cent Eur J Immunol. 2020;45:37-47.
    PubMed         Abstract available

    Curr Opin Urol

  11. SORIA F, Giordano A, Shariat SF, Gontero P, et al
    Bladder sparing landscape for bacillus Calmette-Guerin unresponsive bladder cancer.
    Curr Opin Urol. 2020 May 13. doi: 10.1097/MOU.0000000000000789.
    PubMed         Abstract available

    Eur Rev Med Pharmacol Sci

  12. WU JP, Zhang GY, Sun XZ
    LncRNA ZNFX1-AS1 targeting miR-193a-3p/SDC1 regulates cell proliferation, migration and invasion of bladder cancer cells.
    Eur Rev Med Pharmacol Sci. 2020;24:4719-4728.
    PubMed         Abstract available

    Eur Urol Oncol

  13. NECCHI A, Raggi D, Giannatempo P, Marandino L, et al
    Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 Study.
    Eur Urol Oncol. 2020 May 13. pii: S2588-9311(20)30053.
    PubMed         Abstract available

    J Biomed Mater Res A

  14. CAO H, Huang D, Guo L, Gao Y, et al
    Effects of Different Chemical Groups on Behaviors of Bladder Cancer Cells.
    J Biomed Mater Res A. 2020 May 17. doi: 10.1002/jbm.a.36999.
    PubMed         Abstract available

    Matrix Biol

  15. BURASCHI S, Neill T, Xu SQ, Palladino C, et al
    Progranulin/EphA2 axis: A novel oncogenic mechanism in bladder cancer.
    Matrix Biol. 2020 May 14. pii: S0945-053X(20)30038.
    PubMed         Abstract available

    Mol Cancer Ther

  16. VENA F, Bayle S, Nieto A, Quereda V, et al
    Targeting casein kinase 1 delta sensitizes pancreatic and bladder cancer cells to gemcitabine treatment by upregulating deoxycytidine kinase.
    Mol Cancer Ther. 2020 May 19. pii: 1535-7163.MCT-19-0997.
    PubMed         Abstract available

    Nat Rev Urol

  17. RINK M
    Electronic cigarettes and bladder cancer - a game-changer?
    Nat Rev Urol. 2020 May 20. pii: 10.1038/s41585-020-0337.

    Nucleic Acids Res

  18. LI S, Li P, Ge M, Wang H, et al
    Elucidation of leak-resistance DNA hybridization chain reaction with universality and extensibility.
    Nucleic Acids Res. 2020;48:2220-2231.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  19. KHAN Z, Di Nucci F, Kwan A, Hammer C, et al
    Polygenic risk for skin autoimmunity impacts immune checkpoint blockade in bladder cancer.
    Proc Natl Acad Sci U S A. 2020 May 19. pii: 1922867117.
    PubMed         Abstract available

    Res Rep Urol

  20. WATT J, Maguire DG, Reid CN, Lamont JV, et al
    Thrombomodulin Expression in Bladder Cancer Tissue and Its Association with Prognosis and Patient Survival.
    Res Rep Urol. 2020;12:157-165.
    PubMed         Abstract available

    Sci Rep

  21. CHIU YF, Wu CC, Kuo MH, Miao CC, et al
    Critical role of SOX2-IGF2 signaling in aggressiveness of bladder cancer.
    Sci Rep. 2020;10:8261.
    PubMed         Abstract available

    Transl Androl Urol

  22. CAI Q, Chen Y, Xin S, Zhang D, et al
    Temporal trends of bladder cancer incidence and mortality from 1990 to 2016 and projections to 2030.
    Transl Androl Urol. 2020;9:153-165.
    PubMed         Abstract available

  23. LIU S, Xu F, Xu T, Yan Y, et al
    Evaluation of Vesical Imaging-Reporting and Data System (VI-RADS) scoring system in predicting muscle invasion of bladder cancer.
    Transl Androl Urol. 2020;9:445-451.
    PubMed         Abstract available

  24. MA W, Mao S, Bao M, Wu Y, et al
    Prognostic significance of red cell distribution width in bladder cancer.
    Transl Androl Urol. 2020;9:295-302.
    PubMed         Abstract available

  25. TACHIBANA I, Kaimakliotis HZ
    Tumor downstaging in muscle invasive bladder cancer with neoadjuvant systemic therapy-does it lead to prolonged survival?
    Transl Androl Urol. 2020;9:831-833.

    Urol Oncol

  26. CHIPOLLINI J, Wright JR, Nwanosike H, Kepler CY, et al
    Characterization of urinary microbiome in patients with bladder cancer: Results from a single-institution, feasibility study.
    Urol Oncol. 2020 May 12. pii: S1078-1439(20)30139.
    PubMed         Abstract available

  27. FUJITA N, Hatakeyama S, Momota M, Tobisawa Y, et al
    Impact of substratification on predicting oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.
    Urol Oncol. 2020 May 14. pii: S1078-1439(20)30178.
    PubMed         Abstract available

  28. MATULAY JT, Tabayoyong W, Duplisea JJ, Chang C, et al
    Variability in adherence to guidelines based management of nonmuscle invasive bladder cancer among Society of Urologic Oncology (SUO) members.
    Urol Oncol. 2020 May 16. pii: S1078-1439(20)30181.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.